Sign In

Harith Rajagopalan

Co-Founder and CEO

Harith Rajagopalan, M.D., Ph.D., is a distinguished individual with a remarkable background in medicine, entrepreneurship, and scientific research. He is renowned as the Co-founder and CEO of Fractyl Health, a company he initiated during his tenure as an Entrepreneur-in-Residence at General Catalyst Partners.

In his earlier career, Harith Rajagopalan excelled as an academic cardiologist and physician-scientist. His educational journey began with a Bachelor of Science degree in Chemistry from Stanford University, followed by the completion of his M.D. and Ph.D. degrees from The Johns Hopkins University School of Medicine. At Johns Hopkins, Harith conducted groundbreaking research on intestinal cancers, which garnered recognition by being published in prestigious medical journals such as Nature and Science.

Following his academic pursuits, Harith delved into further medical training at Brigham and Women's Hospital, specializing in internal medicine and clinical cardiology. Additionally, he undertook a research fellowship at the esteemed Harvard Stem Cell Institute within Harvard Medical School, further enriching his expertise in the healthcare domain.

Highlights

May 9 · linkedin

Great article about the next frontier in obesity: weight maintenance. By Betsy McKay in The Wall Street Journal today, featuring Fractyl Health patient journeys and our upcoming Remain-1 pivotal study for people who want to keep weight off after stopping GLP-1s.

Key quotes:

“Drugs or procedures to keep weight off could fuel an even bigger bonanza than Ozempic and its immensely profitable cousins."

"Only 14% of people surveyed in 2023 by @KFF, the health-policy research organization, were interested in taking a weight-loss drug once they were told they might gain weight back if they stopped."

Feb 2 · linkedin

Exciting day for Fractyl Health! No GUTS, no glory!

Harith Rajagopalan
Add to my network

Location

Greater Boston